Investigator meeting completed for Phase 1-2 study in adult participants with relapsed or refractory PTCL
This month GCT has successfully conducted Investigator’s meeting for the international multicenter Phase 1-2 study in adult participants with
relapsed or refractory Peripheral T Cell Lymphoma (PTCL). The study will be conducted across 17 study sites by GCT in the U.S., Russia and Ukraine.
November 30, 2018
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
The Ritz Carlton
2018, December 18-19
Miami Beach Resort
Miami Beach, Florida, USA
2019, January 19-20
Austria Center Vienna, booth #B14
2019, February 5-7
Washington, DC, USA
2019, February 19-21